{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T06:10:56Z","timestamp":1760767856079,"version":"build-2065373602"},"reference-count":18,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[2001,12,1]]},"DOI":"10.1136\/heart.86.6.603","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:32:19Z","timestamp":1027751539000},"page":"603-604","source":"Crossref","is-referenced-by-count":4,"title":["Progress in, and future prospects for, the treatment of primary pulmonary hypertension"],"prefix":"10.1136","volume":"86","author":[{"given":"MARTIN R","family":"WILKINS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHN","family":"WHARTON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2001,12,1]]},"reference":[{"key":"2025101722340404000_86.6.603.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602013340504"},{"key":"2025101722340404000_86.6.603.2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"2025101722340404000_86.6.603.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17100060"},{"key":"2025101722340404000_86.6.603.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801293380501"},{"key":"2025101722340404000_86.6.603.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.25.3130"},{"key":"2025101722340404000_86.6.603.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422503"},{"key":"2025101722340404000_86.6.603.7","first-page":"A477","article-title":"Efficacy and safety of chronic subcutaneous infusion UT-15 in pulmonary arterial hypertension (PAH) [abstract].","volume":"102 (suppl II)","author":"Barst","year":"2000","journal-title":"Circulation"},{"key":"2025101722340404000_86.6.603.8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0002-9149(96)90408-7","article-title":"Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension.","volume":"78","author":"Saji","year":"1996","journal-title":"Am J Cardiol"},{"key":"2025101722340404000_86.6.603.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00312-5"},{"key":"2025101722340404000_86.6.603.10","doi-asserted-by":"publisher","DOI":"10.1136\/heart.86.6.661"},{"key":"2025101722340404000_86.6.603.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.4.411"},{"key":"2025101722340404000_86.6.603.12","unstructured":"Channick RN, Rubin LJ, Simonneau G, et al. Bosentan, a dual endothelin receptor antagonist, improves exercise capacity and haemodynamics in patients with pulmonary arterial hypertension: results of a double blind, randomized, placebo-controlled trial. Circulation2000;102(suppl II).."},{"key":"2025101722340404000_86.6.603.13","doi-asserted-by":"publisher","DOI":"10.1161\/hc2901.093117"},{"key":"2025101722340404000_86.6.603.14","doi-asserted-by":"publisher","DOI":"10.1136\/heart.84.2.e4"},{"key":"2025101722340404000_86.6.603.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011023431814"},{"key":"2025101722340404000_86.6.603.16","doi-asserted-by":"publisher","DOI":"10.1086\/303059"},{"key":"2025101722340404000_86.6.603.17","doi-asserted-by":"publisher","DOI":"10.1038\/79226"},{"key":"2025101722340404000_86.6.603.18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1101\/gad.14.6.627","article-title":"Controlling TGF-beta signaling.","volume":"14","author":"Massague","year":"2000","journal-title":"Genes Dev"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heart.86.6.603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T05:34:12Z","timestamp":1760765652000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heart.86.6.603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2001,12,1]]},"published-print":{"date-parts":[[2001,12,1]]}},"alternative-id":["10.1136\/heart.86.6.603"],"URL":"https:\/\/doi.org\/10.1136\/heart.86.6.603","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[2001,12,1]]}}}